These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2369097)

  • 1. Daunorubicin coupled to monoclonal antibodies via a cis-aconitic anhydride linker: biochemical and cytotoxic properties revisited.
    Ahmad A; Law KL; Young B; Telander MW; Ogden JR; Leung K
    Anticancer Res; 1990; 10(3):837-43. PubMed ID: 2369097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor reactive cis-aconitylated monoclonal antibodies coupled to daunorubicin through a peptide spacer are unable to kill tumor cells.
    Law KL; Studtmann KE; Carlson RE; Swanson TA; Buirge AW; Ahmad A
    Anticancer Res; 1990; 10(3):845-52. PubMed ID: 2369098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment.
    Gaudreault RC; Bellemare B; Lacroix J
    Anticancer Res; 1989; 9(4):1201-5. PubMed ID: 2817803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.
    Dillman RO; Johnson DE; Shawler DL; Koziol JA
    Cancer Res; 1988 Nov; 48(21):6097-102. PubMed ID: 3262420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity.
    Ogden JR; Leung K; Kunda SA; Telander MW; Avner BP; Liao SK; Thurman GB; Oldham RK
    Mol Biother; 1989; 1(3):170-4. PubMed ID: 2604916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
    Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
    Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugates.
    Jeffrey SC; Andreyka JB; Bernhardt SX; Kissler KM; Kline T; Lenox JS; Moser RF; Nguyen MT; Okeley NM; Stone IJ; Zhang X; Senter PD
    Bioconjug Chem; 2006; 17(3):831-40. PubMed ID: 16704224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
    Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effects of anthracycline derivatives on a human adenocarcinoma cell line (LoVo) grown as a monolayer and as spheroids.
    Soranzo C; Ingrosso A
    Anticancer Res; 1988; 8(3):369-73. PubMed ID: 3389741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for inhibition of growth related to compromised DNA synthesis in the interaction of daunorubicin with H-35 rat hepatoma.
    Munger C; Ellis A; Woods K; Randolph J; Yanovich S; Gewirtz D
    Cancer Res; 1988 May; 48(9):2404-11. PubMed ID: 3356005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
    Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of daunorubicin on ganglioside expression and neuronal differentiation of mouse embryonic stem cells.
    Lee DH; Koo DB; Ko K; Ko K; Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Do SI; Jung KY; Choo YK
    Biochem Biophys Res Commun; 2007 Oct; 362(2):313-8. PubMed ID: 17707770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Dorvillius M; Garambois V; Glaussel F; Larroque C; Langlois R; Hynes NE; van Lier JE; Pèlegrin A
    Br J Cancer; 2001 Nov; 85(11):1787-93. PubMed ID: 11742503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.